Literature DB >> 23891428

A simple validated clinical tool to predict the absence of coronary artery disease in patients with systolic heart failure of unclear etiology.

Rami Doukky1, Michael J Shih, Mouyyad Rahaby, Tareq Alyousef, Salaheldin Abusin, Najamul H Ansari, Russell F Kelly.   

Abstract

Coronary artery disease (CAD) is a major cause of systolic heart failure (HF). Identifying CAD as a cause of systolic HF has prognostic and treatment implications. Whether all patients with systolic HF of unclear etiology should undergo coronary angiography has been controversial. We sought to derive and validate a clinical prediction rule to exclude CAD as a cause of systolic HF. A derivation cohort was formed of consecutive patients who had undergone coronary angiography with a primary diagnosis of systolic HF of unclear etiology (ejection fraction <50%). Using multivariate logistic regression analysis, we derived a prediction rule for severe CAD (≥50% diameter stenosis in the left main, 3-vessel CAD, and 2-vessel CAD involving the proximal left anterior descending artery). The diagnostic performance of the defined prediction rule was prospectively validated in a separate cohort recruited from 2 institutions. Of the 124 patients in the derivation cohort, 27% had CAD, including 15% with severe CAD. The independent predictors of severe CAD included diabetes (odds ratio 5.1, p = 0.005), electrocardiographic Q waves or left bundle branch block (odds ratio 3.8, p = 0.02), and ≥2 nondiabetes risk factors: age (men ≥55 or women ≥65 years), dyslipidemia, hypertension, and tobacco use (odds ratio 4.8, p = 0.02). A prediction rule of having ≥1 independent predictor identified 97% of the patients with CAD and 100% of the patients with severe CAD. In the prospective validation cohort of 143 patients, the prediction rule had 98% sensitivity and 18% specificity for CAD but 100% sensitivity for severe CAD. In conclusion, a simple clinical prediction rule can accurately identify patients with CAD and eliminate the need for angiography in a substantial proportion of patients with systolic HF, with potentially significant cost savings and risk avoidance.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23891428     DOI: 10.1016/j.amjcard.2013.05.078

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging.

Authors:  Rami Doukky; Adebayo Olusanya; Raj Vashistha; Abhimanyu Saini; Ibtihaj Fughhi; Khaled Mansour; Abiy Nigatu; Kara Confer; Shannon A Sims
Journal:  J Nucl Cardiol       Date:  2015-04-24       Impact factor: 5.952

2.  Prevalence of non-acute ischaemic cardiomyopathy in a Pakistani cohort.

Authors:  Muhammad Salman Ghazni; Saba Aijaz; Rehan Malik; Asad Z Pathan
Journal:  Heart Asia       Date:  2019-03-25

3.  Performance of Coronary Angiography in the Detection of Coronary Artery Disease in Patients with Systolic Left Ventricular Dysfunction and No Prior Ischemic Heart Disease.

Authors:  Óscar M Peiró; Maria Ferrero; Alba Romeu; Anna Carrasquer; Gil Bonet; Mohsen Mohandes; Alberto Pernigotti; Alfredo Bardají
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

4.  Temporal changes in the pattern of invasive angiography use and its outcome in suspected coronary artery disease: implications for patient management and healthcare resources utilization.

Authors:  Jakub Chmiel; Miłosz K Książek; Weronika Stryszak; Paweł Iwaszczuk; Mateusz K Hołda; Grażyna Świtacz; Artur Kozanecki; Piotr Wilkołek; Paweł Rubiś; Grzegorz Kopeć; Piotr Odrowąż-Pieniążek; Tadeusz Przewłocki; Wiesława Tracz; Piotr Podolec; Piotr Musiałek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.